医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

TeamBest Global Companies & Best Cyclotron Systems, Inc. Announce Shipment of World’s Very First 6 MeV Proton Cyclotron

2022年01月27日 AM07:18
このエントリーをはてなブックマークに追加


 

OTTAWA, Ontario & VANCOUVER, British Columbia & WASHINGTON & BEIJING

TeamBest Global Companies (TBG) and Best Cyclotron Systems, Inc. (BCS) announce the shipment of the world’s very first 6 MeV Proton Cyclotron, operating in excess of 500 micro amp current, to a National Lab today. The design, development and manufacture was a combined effort of BCS’s Vancouver, Canada facility and Best Theratronics Ltd. manufacturing facility in Ottawa, Canada. This cyclotron is the first of multiple High Current Proton Cyclotrons that the TeamBest Global Companies will be shipping in the coming months of 2022.

BCS is a leader in the design, development and manufacture of novel cyclotrons for production of isotopes and neutron beams for health care institutions, research and academic centers.

For more information about TeamBest Global Companies and Best Cyclotron Systems, please visit:
www.teambest.com
www.bestcyclotron.com
www.theratronics.com
www.bestabt.com
www.bestcure.md

To read most recent news from TeamBest Global Companies, please visit: http://www.teambest.com/news_press.html.

For more information about Krishnan Suthanthiran, please visit his bio page at http://www.teambest.com/about_bio.html.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220126006037/en/

CONTACT

Krishnan Suthanthiran • President & Founder

TeamBest Global Companies & Best Cure Foundation

7643 Fullerton Road, Springfield, VA 22153 USA

+1 703-451-2378

marketing@teambest.com

同じカテゴリーの記事 

  • NADclinic和Bontac Bio-Engineering (Shenzhen) Co., Ltd宣布建立战略合作伙伴关系,通过NAD+的力量开拓全球健康的未来
  • Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
  • Brenmiller’s Project Pipeline Expands to 49 Projects Representing Over $500 Million in Potential Value in 12 Industries Across 13 Countries
  • NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+
  • Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients